Bring the study you have in mind
Tell us the indication, the phase and who would be eligible, and we’ll come back with the clinics that could run it and the markers they read.
Tell us about the study
What to bring
The indication and the phase
The condition, the therapy class and where the program stands today.
Who would be eligible
Your inclusion and exclusion criteria, as far as you have them. A synopsis is plenty.
What you need to read
The endpoint or biomarker the study has to answer on.
Your questions for us
How your criteria meet these patients, how a study would be set up with each clinic, investigators, inspection and access to source records. That is what this conversation is for. Any study runs on de-identified data, with each patient’s consent and under ethics review.
Other ways to reach us
Running a clinic
Bring a protocol you run, and we walk one patient through it.
Request a walkthroughInvestors and collaborators
Compare notes with us on where n‑of‑1 medicine is going.
Start the conversationEmail
Send us a note directly, and we reply within one business day.
info@iksa.ai
Before we talk
The CEO and COO of the group we built iksa with tell how the work began and where it went · 2:38
- Who you’ll be talking to
- People from medicine, clinical trials and AI software, with Shaun Verma, our founder and CEO, guiding the work.
- Meet the team
- Your security review
- We sign a BAA with every clinic before any patient data moves, and we work through your security review with you.
- Security and trust